Please use this identifier to cite or link to this item:
http://hdl.handle.net/10603/360617
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.coverage.spatial | Pharmacy | |
dc.date.accessioned | 2022-02-07T09:05:10Z | - |
dc.date.available | 2022-02-07T09:05:10Z | - |
dc.identifier.uri | http://hdl.handle.net/10603/360617 | - |
dc.description.abstract | quotMidodrine Hydrochloride is mainly used in to treat orthostatic hypotension. Problem associated with current immediate release tablet of Midodrine Hydrochloride is it requires three or four dosing per day for symptomatic relief from orthostatic hypotension. (Half Life is 3-4 hrs). Therefore, there is a need to reduce the variability of such type of molecule / product by preparation of Modified release dosage form by using different concentration of polymers. newlineMidodrine Hydrochloride is mainly used for treatment of orthostatic hypotension. The purpose of the development of modified release dosage form is to minimizing the frequency of dosing while maintaining therapeutic concentration. The objective of the present research work is to formulate and evaluate modified release capsules and bilayer tablets of Midodrine Hydrochloride by applying QbD approaches using various tooling for optimization of drug products. For capsule dosage form: MCC sphere were drug layered, Polymer coated and again drug layered using fluid bed processor to achieve desired drug release over extended period of time. For Bilayer tablets: Immediate release and extended release layer compressed and % drug release was measured. Central composite design (CCD) was employed for both the formulation and % of drug release was measured at 2, 4, 8 and 12 hrs. Stability study carried out for final formulation and there is no any major changes observed for % drug release over 12 hours. newlinequot newline | |
dc.format.extent | - | |
dc.language | English | |
dc.relation | No of References 60 | |
dc.rights | university | |
dc.title | Development of modified release dosage form of midodrine hydrochloride using quality by design approach | |
dc.title.alternative | ||
dc.creator.researcher | Kheni. Pratik | |
dc.subject.keyword | Bilayered-tablets | |
dc.subject.keyword | Clinical Pre Clinical and Health | |
dc.subject.keyword | Drug layered Pellets | |
dc.subject.keyword | ER layered Pellets | |
dc.subject.keyword | Fluid Bed Processor | |
dc.subject.keyword | Midodrine Hydrochloride (MDH) | |
dc.subject.keyword | Orthostatic Hypotension | |
dc.subject.keyword | Pharmacology and Pharmacy | |
dc.subject.keyword | Pharmacology and Toxicology | |
dc.subject.keyword | QTPP, CQA, CCP | |
dc.description.note | References p. 140-144, Appendix p. 147-148 | |
dc.contributor.guide | Mehta, Dharmik | |
dc.publisher.place | Rajkot | |
dc.publisher.university | RK University | |
dc.publisher.institution | Faculty of Medicine | |
dc.date.registered | 2018 | |
dc.date.completed | 2022 | |
dc.date.awarded | 2022 | |
dc.format.dimensions | - | |
dc.format.accompanyingmaterial | None | |
dc.source.university | University | |
dc.type.degree | Ph.D. | |
Appears in Departments: | Faculty of Pharmacy |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
01_cover page.pdf | Attached File | 98.53 kB | Adobe PDF | View/Open |
02_certificate.pdf | 3 MB | Adobe PDF | View/Open | |
03_declaration.pdf | 99.4 kB | Adobe PDF | View/Open | |
04_acknowledgement.pdf | 93.16 kB | Adobe PDF | View/Open | |
05_table of contents.pdf | 127.21 kB | Adobe PDF | View/Open | |
06_list of tables.pdf | 131.97 kB | Adobe PDF | View/Open | |
07_list of figures.pdf | 127.3 kB | Adobe PDF | View/Open | |
08_ list of abbreviations.pdf | 95 kB | Adobe PDF | View/Open | |
09_abstract.pdf | 94.93 kB | Adobe PDF | View/Open | |
10_graphical abstract.pdf | 265.16 kB | Adobe PDF | View/Open | |
11_chapter 1_introduction.pdf | 192.94 kB | Adobe PDF | View/Open | |
12_chapter 2_objective.pdf | 96.21 kB | Adobe PDF | View/Open | |
13_chapter 3_materials and methods.pdf | 462.36 kB | Adobe PDF | View/Open | |
14_chapter 4_results and discussion.pdf | 3.6 MB | Adobe PDF | View/Open | |
15_chapter 5_summary and conclusion.pdf | 99.46 kB | Adobe PDF | View/Open | |
16_references.pdf | 133.48 kB | Adobe PDF | View/Open | |
17_list of publication.pdf | 369.27 kB | Adobe PDF | View/Open | |
18_appendix.pdf | 287.62 kB | Adobe PDF | View/Open | |
80_recommendation.pdf | 183.9 kB | Adobe PDF | View/Open |
Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).
Altmetric Badge: